Correlation between joint [F-18] FDG PET uptake and synovial TNF-α concentration: A study with two rabbit models of acute inflammatory arthritis

Applied Radiation and Isotopes

Volumn 65, Issue 11, 2007, Pages 1221-1226

  Lin, Po Wei ^a   Liu, Ren Shyan ^b   Liou, Tsan Hon ^a   Pan, Li Chern ^a   Chen, Chi Hsien ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

18F fluoro 2 deoxyglucose; Arthritis severity; Inflammatory arthritis; Positron emission tomography; Tumor necrosis factor alpha

Indexed keywords

ARTHRITIS SEVERITY; INFLAMMATORY ARTHRITIS; TUMOR NECROSIS FACTOR ALPHA;

ANIMALS; CONCENTRATION (PROCESS); PHYSIOLOGICAL MODELS; POLYSACCHARIDES; STATISTICAL METHODS;

POSITRON EMISSION TOMOGRAPHY;

FLUORODEOXYGLUCOSE F 18; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RABBIT; SYNOVIAL FLUID;

ANIMALS; ARTHRITIS; DISEASE MODELS, ANIMAL; FLUORODEOXYGLUCOSE F18; HUMANS; INFLAMMATION; INTERLEUKIN-8; JOINTS; LIPOPOLYSACCHARIDES; POSITRON-EMISSION TOMOGRAPHY; RABBITS; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 35348928278     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2007.06.006     Document Type: Article

References (31)

1. 18F-FDG PET. J. Nucl. Med. 45 6 (2004) 956-964
2. Bhoola K.D., Elson C.J., and Dieppe P.A. Kinins-key mediators in inflammatory arthritis?. Br. J. Rheumatol. 31 8 (1992) 509-518
3. 18F-FDG PET in rheumatoid arthritis: there still is a long way to go. J. Nucl. Med. 45 6 (2004) 927-929
4. Dehdashti F., Mortimer J.E., Siegel B.A., Griffeth L.K., Bonasera T.J., Fusselman M.J., Detert D.D., Cutler P.D., Katzenellenbogen J.A., and Welch M.J. Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays. J. Nucl. Med. 36 10 (1995) 1766-1774
5. Eberl D.R., Fasching V., Rahlfs V., Schleyer I., and Wolf R. Repeatability and objectivity of various measurements in rheumatoid arthritis. A comparative study. Arthritis. Rheum. 19 6 (1976) 1278-1286
6. Emshoff R., Puffer P., Rudisch A., and Gassner R. Temporomandibular joint pain: relationship to internal derangement type, osteoarthrosis, and synovial fluid mediator level of tumor necrosis factor-α. Oral Surg. Oral Med. Oral Pathol. 90 4 (2000) 442-449
7. In: Hubner K.F., Collmann J., Buonocore E., and Kabalka G.W. (Eds). Clinical Positron Emission Tomography (1992), Mosby Year Book, St. Louis pp. 50-77
8. Ivashkiv L.B. Cytokine expression and cell activation in inflammatory arthritis. Adv. Immunol. 63 (1996) 337-376
9. Keyes Jr. J.W. SUV: standard uptake or silly useless value?. J. Nucl. Med. 36 10 (1995) 1836-1839
10. Kowal K., and Weinstein A. Western blot band intensity analysis. Application to the diagnosis of Lyme arthritis. Arthritis. Rheum. 37 8 (1994) 1206-1211
11. Laubenbacher C., Saumweber D., Wagner-Manslau C., Kau R.J., Herz M., Avril N., Ziegler S., Kruschke C., Arnold W., and Schwaiger M. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J. Nucl. Med. 36 10 (1995) 1747-1757
12. Lee D.M., and Weinblatt M.E. Rheumatoid arthritis. Lancet 358 9285 (2001) 903-911
13. Loening A.M., and Gambhir S.S. AMIDE: a free software tool for multimodality medical image analysis. Mol. Imag. 2 3 (2003) 131-137
14. Marzo-Ortega H., McGonagle D., Jarrett S., Haugeberg G., Hensor E., O'connor P., Tan A.L., Conaghan P.G., Greenstein A., and Emery P. Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study. Ann. Rheum. Dis. 64 11 (2005) 1568-1575
15. Nordahl S., Alstergren P., Eliasson S., and Kopp S. Interleukin-1beta in plasma and synovial fluid in relation to radiographic changes in arthritic temporomandibular joints. Eur. J. Oral Sci. 106 1 (1998) 559-563
16. Palmer W.E., Rosenthal D.I., Schoenberg O.I., Fischman A.J., Simon L.S., Rubin R.H., and Polisson R.P. Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy-d-glucose. Radiology 196 3 (1995) 647-655
17. Podolin P.L., Bolognese B.J., Foley J.J., Schmidt D.B., Buckley P.T., Widdowson K.L., Jin Q., White J.R., Lee J.M., Goodman R.B., Hagen T.R., Kajikawa O., Marshall L.A., Hay D.W., and Sarau H.M. A potent and selective nonpeptide antagonist of CXCR2 inhibits acute and chronic models of arthritis in the rabbit. J. Immunol. 169 11 (2002) 6435-6444
18. Polisson R.P., Schoenberg O.I., Fischman A., Rubin R., Simon L.S., Rosenthal D., and Palmer W.E. Use of magnetic resonance imaging and positron emission tomography in the assessment of synovial volume and glucose metabolism in patients with rheumatoid arthritis. Arthritis. Rheum. 38 6 (1995) 819-825
19. Punzi L., Calo L., and Plebani M. Clinical significance of cytokine determination in synovial fluid. Crit. Rev. Clin. Lab. Sci. 39 1 (2002) 63-88
20. Reginster J.Y. The prevalence and burden of arthritis. Rheumatology (Oxford) 41 Suppl. 1 (2002) 3-6
21. Rodriguez M., Rehn S., Ahlstrom H., Sundstrom C., and Glimelius B. Predicting malignancy grade with PET in non-Hodgkin's lymphoma. J. Nucl. Med. 36 10 (1995) 1790-1796
22. 18F-fluoro-2-deoxy-d-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium. Arthritis. Rheum. 48 11 (2003) 3077-3084
23. Schwarz E.M., Campbell D., Totterman S., Boyd A., O'Keefe R.J., and Looney R.J. Use of volumetric computerized tomography as a primary outcome measure to evaluate drug efficacy in the prevention of peri-prosthetic osteolysis: a 1-year clinical pilot of etanercept vs placebo. J. Orthop. Res. 21 6 (2003) 1049-1055
24. Scott D.L., Laasonen L., Priolo F., Houssien D.A., Bacarini L., Cerase A., and Cammisa M. The radiological assessment of rheumatoid arthritis. Clin. Exp. Rheumatol. 15 Suppl. 17 (1997) S53-S61
25. Segami N., Miyamaru M., Nishimura M., Suzuki T., Kaneyama K., and Murakami K. Does joint effusion on T2 magnetic resonance images reflect synovitis? Part 2. Comparison of concentration levels of proinflammatory cytokines and total protein in synovial fluid of the temporomandibular joint with internal derangements and osteoarthrosis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 94 4 (2002) 515-521
26. Voog U., Alstergren P., Eliasson S., Leibur E., Kallikorm R., and Kopp S. Inflammatory mediators and radiographic changes in temporomandibular joints of patients with rheumatoid arthritis. Acta Odontol. Scand. 61 1 (2003) 57-64
27. Wipke B.T., Wang Z., Kim J., McCarthy T.J., and Allen P.M. Dynamic visualization of a joint-specific autoimmune response through positron emission tomography. Nat. Immunol. 3 4 (2002) 366-372
28. Woolf A.D., and Pfleger B. Burden of major musculoskeletal conditions. Bull. WHO 81 9 (2003) 646-656
29. Wunder A., Straub R.H., Gay S., Funk J., and Muller-Ladner U. Molecular imaging: novel tools in visualizing rheumatoid arthritis. Rheumatology (Oxford) 44 11 (2005) 1341-1349
30. Yun M., Kim W., Adam L.E., Alnafisi N., Herman C., and Alavi A. F-18 FDG uptake in a patient with psoriatic arthritis: imaging correlation with patient symptoms. Clin. Nucl. Med. 26 8 (2001) 692-693
31. Zar J.H. Testing for goodness of fit. In: Biostatistical Analysis. second ed (1984), Prentice-Hall, Englewood Cliffs, NJ pp. 306-327